L&K Biomed Ltd. (KOSDAQ: 156100)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,570.00
-50.00 (-0.76%)
Sep 11, 2024, 2:55 PM KST

L&K Biomed Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
30,49629,90519,76715,37319,35626,575
Upgrade
Other Revenue
-0-0-0-0-0
Upgrade
Revenue
30,49629,90519,76715,37319,35626,575
Upgrade
Revenue Growth (YoY)
12.08%51.28%28.59%-20.58%-27.16%-15.16%
Upgrade
Cost of Revenue
4,1624,2274,9758,0195,89913,932
Upgrade
Gross Profit
26,33425,67814,7927,35413,45712,643
Upgrade
Selling, General & Admin
21,33220,96724,26119,64713,69614,842
Upgrade
Research & Development
1,4231,3291,3691,358977.971,915
Upgrade
Operating Expenses
25,10223,64427,53022,63417,31521,934
Upgrade
Operating Income
1,2322,034-12,738-15,280-3,859-9,291
Upgrade
Interest Expense
-1,736-2,002-2,206-1,380-1,145-2,045
Upgrade
Interest & Investment Income
488.26384.99219.84107.61127.55215.82
Upgrade
Earnings From Equity Investments
-1,469-1,172-1,199-556.16-420.88-227.95
Upgrade
Currency Exchange Gain (Loss)
2,587740.731,9612,301-1,707670.8
Upgrade
Other Non Operating Income (Expenses)
-1,505-330.56-2,0274,630639.473,235
Upgrade
EBT Excluding Unusual Items
-402.77-343.96-15,989-10,178-6,365-7,443
Upgrade
Gain (Loss) on Sale of Investments
49.4149.41-1,684--
Upgrade
Gain (Loss) on Sale of Assets
91.6816.24-65.73220.44-519.34-856.45
Upgrade
Asset Writedown
-16.8-16.8-243.71-623.87-2,355-5,540
Upgrade
Other Unusual Items
-4,385-6,173----
Upgrade
Pretax Income
-4,663-6,468-16,299-8,897-9,239-13,839
Upgrade
Income Tax Expense
-1,578-1,229-65.764,7491,433-2,266
Upgrade
Earnings From Continuing Operations
-3,085-5,239-16,233-13,646-10,672-11,573
Upgrade
Minority Interest in Earnings
3,7503,3722,6083,978-43.26806.4
Upgrade
Net Income
664.93-1,867-13,625-9,669-10,715-10,766
Upgrade
Net Income to Common
664.93-1,867-13,625-9,669-10,715-10,766
Upgrade
Shares Outstanding (Basic)
201613131210
Upgrade
Shares Outstanding (Diluted)
201613131210
Upgrade
Shares Change (YoY)
45.67%21.04%0.07%12.57%14.15%5.11%
Upgrade
EPS (Basic)
34.09-115.17-1017.14-722.29-901.11-1033.51
Upgrade
EPS (Diluted)
34.09-115.17-1017.14-722.29-901.11-1034.00
Upgrade
Free Cash Flow
-8,355-3,417-6,684-10,501-2,721-575.28
Upgrade
Free Cash Flow Per Share
-428.29-210.77-498.99-784.49-228.82-55.22
Upgrade
Gross Margin
86.35%85.87%74.83%47.84%69.52%47.58%
Upgrade
Operating Margin
4.04%6.80%-64.44%-99.40%-19.94%-34.96%
Upgrade
Profit Margin
2.18%-6.24%-68.93%-62.89%-55.36%-40.51%
Upgrade
Free Cash Flow Margin
-27.40%-11.43%-33.81%-68.31%-14.06%-2.16%
Upgrade
EBITDA
3,6294,347-10,436-13,555-770.01-5,811
Upgrade
EBITDA Margin
11.90%14.54%-52.80%-88.18%-3.98%-21.87%
Upgrade
D&A For EBITDA
2,3972,3132,3021,7253,0893,480
Upgrade
EBIT
1,2322,034-12,738-15,280-3,859-9,291
Upgrade
EBIT Margin
4.04%6.80%-64.44%-99.40%-19.94%-34.96%
Upgrade
Advertising Expenses
-130.35176.7178.0768.79348.33
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.